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Abstract Sphingolipids (SP) are a complex class of
molecules found in essentially all eukaryotes and some
prokaryotes and viruses where they inﬂuence membrane
structure, intracellular signaling, and interactions with the
extracellular environment. Because of the combinatorial
nature of their biosynthesis, there are thousands of SP
subspecies varying in the lipid backbones and complex
phospho- and glycoheadgroups. Therefore, comprehensive
or ‘‘sphingolipidomic’’ analyses (structure-speciﬁc, quanti-
tative analyses of all SP, or at least all members of a critical
subset) are needed to know which and how much of these
subspecies are present in a system as a step toward under-
standing their functions. Mass spectrometry and related
novel techniques are able to quantify a small fraction, but
nonetheless a substantial number, of SP and are beginning
to provide information about their localization. This review
summarizes the basic metabolism of SP and state-of-art
mass spectrometric techniques that are producing insights
into SP structure, metabolism, functions, and some of the
dysfunctions of relevance to neuromedicine.
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Introduction
Sphingolipids (SP)
1 are, even today, often thought of as
‘‘brain lipids’’ because many bear names such as sphingo-
myelins, cerebrosides, gangliosides, etc. They are a com-
plex class of molecules that are found in essentially all
animals, plants and fungi, and some prokaryotic organisms
and viruses (Merrill et al. 2007). They are deﬁned as a
category by the presence of a sphingoid base backbone
(mainly sphingosines, So; sphinganines, Sa; and phytosp-
hingosines in mammals, but a wide range of additional
species are known) (Pruett et al. 2008) to which can be
attached amide-linked fatty acids and (or) a headgroup at
the primary hydroxyl. The headgroups range in complexity
from a simple H in ceramide (Cer) to highly complex gly-
coconjugates (Merrill et al. 2007; Lopez and Schnaar 2009).
SP serve as structural components of membranes, lipo-
proteins, skin and other biomaterials, and as cell-signaling
modulators and mediators. They are located in multiple
intracellular organelles, including the plasma membrane,
intracellular vesicles and associated organelles (Golgi
membranes, endosomes, etc.), mitochondria and even the
nucleus (Ledeen and Wu 2008). In some cases, they are
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referred to as ‘‘rafts’’ where they can inﬂuence the locali-
zation and functions of transporters and receptors, such as
the AMPA receptor in neurons (Hou et al. 2008). The
properties of SP have been reviewed recently for sphingoid
bases and Cers (Goni and Alonso 2006; Zheng et al. 2006;
Goni and Alonso 2009), and for Cers and more complex
species (Maggio et al. 2006; Hakomori 2008; Merrill 2008;
Lopez and Schnaar 2009).
The complex carbohydrate moieties of SP are often sig-
natures for particular cell types, and mediate interactions
with complementary ligands, such as extracellular matrix
proteins and receptors (Hakomori 2000), including direct
carbohydrate–carbohydrate binding with headgroups on
neighboring cells. For example, gangliosides interact with
glycan-binding proteins involved in regulation of nervous
system (Quarles 2007; Lopez and Schnaar 2009). SP can
interact with proteins on the same cell surface to control the
location of the protein (for example, in membrane rafts with
other signaling proteins) and modify the conformation of
receptors and their activities (Hakomori et al. 1998; Yoon
etal.2006).Thefunctionalunitinwhich glycosphingolipids
(GSP)play important rolesincellsurface signaling hasbeen
referred to as a ‘‘glycosynapse’’ (Hakomori 2002, 2008).
The lipid backbones of SP and their metabolites
(sphingoid bases, sphingoid base 1-phosphates, ceramides,
ceramide 1-phosphates, and others) serve as mediators of
intracellular and extracellular signaling in essentially every
type of cell examined, including neurons (Buccoliero and
Futerman 2003). The number of biological functions they
regulate is large and continues to grow, including neuronal
growth (Schwarz et al. 1995; Schwarz and Futerman 1997),
differentiation (Milstien et al. 2007) and death (Coetzee
et al. 1996; Jana et al. 2009). Thus, it is not surprising that
sphingolipids participate in the traditional paradigm of
lipid signaling wherein a complex lipid is cleaved to a
bioactive backbone that activates or inhibits downstream
target(s), but it is somewhat more novel that at least some
of the mediators appear also to be generated by de novo
biosynthesis (Zheng et al. 2006; Bartke and Hannun 2009).
These changes in lipid composition are also likely to alter
the properties of the membranes where these conversions
take place, increasing or decreasing the rafts and other
structures (Hartel et al. 2005; Goni and Alonso 2006),
membrane curvature (Goni et al. 2005), transbilayer (ﬂip-
ﬂop) movement of lipids (Contreras et al. 2005) and other
related molecules (Siskind et al. 2006).
This review provides an overview of the basic structures
of sphingolipids and their metabolism, then discusses some
of the state-of-art technologies that exist and are in
development for sphingolipid analysis. It is hoped that this
information may help readers understand and study the
roles of SP in neuroscience and neuromedicine.
Sphingolipid Structures
Sphingoid bases vary in alkyl chain length, the position and
number of double bonds and hydroxyl groups, and other
features (Pruett et al. 2008) Sphingosine (So) is the pre-
valent backbone of most mammalian SP and refers spe-
ciﬁcally to (2S,3 R,4 E)-2-aminooctadec-4-ene-1, 3-diol
and is also referred to as ‘‘trans-4-sphingenine’’. A con-
venient nomenclature for sphingoid bases is to give the
number of hydroxyl groups (d for the two, di-, hydroxyls of
So and Sa and t, for tri-, for 4-hydroxysphinganine, which
is often called phytosphingosine) followed by the chain
length (typically 18 carbons) and number of double bonds
(most often 0, 1 or sometimes 2); therefore, So is abbre-
viated ‘‘d18:1,’’ Sa as ‘‘d18:0’’, and phytosphingosine as
‘‘t18:0’’. The most common structural variations from these
sphingoid bases for mammals are the longer chain eico-
sasphingosines (C20-So or d20:1) found in brain ganglio-
sides (Colsch et al. 2004), and the presence of a second
double bond (d18:2) in some of the sphingolipids found in
plasma and brain (Karlsson 1970; Levery 2005; Pruett et al.
2008) (Fig. 1a).
The amide-linked fatty acids found in ceramides also
vary in chain length (typically 14–36 carbon atoms),
degree of unsaturation (most are saturated, but in some
special cases, the fatty acids are highly unsaturated
(Sandhoff et al. 2005), and presence or absence of a
hydroxyl group on a or x carbon atom (Fig. 1a). A simple
nomenclature to provide information about both the
sphingoid base and the fatty acid of these more complex
species has the sphingoid base abbreviation followed by
the fatty acid; for example, N-palmitoylsphingosine is
abbreviated ‘‘d18:1/16:0’’.
The phosphosphingolipids subcategory includes the
sphingoid base 1-phosphates, Cer 1-phosphates (Cer1P),
and sphingomyelins (SM), the most prevalent phosphos-
phingolipid in most mammalian cells, but additional spe-
cies such as sphingosylphosphocholine (also referred to as
lysoSM) and ceramide phosphoethanolamine (Liliom et al.
2001) are also noted.
The major carbohydrates of mammalian GSP are listed
in Fig. 1c. The GSP nomenclature (Chester 1998; Fahy
et al. 2005) is more complicated by having both common
names (such as ‘‘ganglioside GM1a’’ shown in Fig. 1c) and
systematic structural nomenclatures (the same compound
can be named Neu5Aca2-3(Galb1-3GalNAcb1-4)Galb1-
4Glcb1Cer (d18:1/16:0)) or II
3-a-N-acetylneuraminosyl-
gangliotetraosylCer (abbreviated II
3-a-Neu5NacGg4Cer)
by a fairly commonly used system where subcategory
(ganglio-, globo-, etc.) connote the root structure for the
category, Roman numerals show location of speciﬁed
carbohydrates, such as sialic acid or other carbohydrate
branchpoints) and Arabic superscripts designate the
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Sphingolipid Metabolism
Sphingolipid Biosynthesis
The de novo biosynthesis of most SP begins with con-
densation of L-serine and palmitoyl-CoA by serine
palmitoyltransferase (SPT) to form 3-ketosphinganines
(Merrill 2002; Hanada 2003) (Fig. 2a). For mammals and
yeast, at least two gene products (termed SPTLC1 and
SPTLC2, or sometimes SPT1 and SPT2) are necessary for
activity (Dickson et al. 2000) and appear to be physically
associated (Gable et al. 2000; Hanada et al. 2000). Another
SPTLC2-like gene (SPTLC3) has been also discovered, the
gene product has been expressed and involved in SPT
activity (Hornemann et al. 2006).
As the ﬁrst unique enzyme of this pathway, SPT is
undoubtedly very important in specifying the amounts and
types of sphingoid bases made. Mutations in SPTLC1 are
associated with hereditary sensory and autonomic neurop-
athy type I (Bejaoui et al. 2001; Dawkins et al. 2001). And
whereas SPT has been thought to only utilize L-serine as its
amino acid substrate, recent studies have revealed that
L-alanine is used to form a novel sphingoid base, 1-deoxy-
sphinganine (1-deoxySa) (Zitomer et al. 2009). Further-
more, D-serine is a competitive inhibitor with an IC50 that is
similar to the Km for L-serine (Hanada et al. 2000), and this
has implications for the mammalian brain that has sub-
stantial amounts of D-serine predominantly localized to the
forebrain structure (Hashimoto and Oka 1997). SPT is also
highly selective for the co-substrate fatty acyl-CoA
with the mammalian enzyme, utilizing palmitoyl-CoA
(C16:0)[pentadecanoyl- and heptadecanoyl-CoAs (C15:0
and C17:0)[[stearoyl-CoA (C18:0), and essentially no
unsaturated species except palmitelaidic (16:1 with a trans-
double bond) (Williams et al. 1984; Hanada et al. 2000).
This differs from the case when SPT is comprised of
SPTLC3, which has a preference for myristoyl-CoA and
makes the d16:0 family sphingoid bases (Hornemann et al.
2009).
In the next steps, the 3-ketosphinganine is reduced to Sa
by 3-ketosphinganine reductase (Mandon et al. 1992) fol-
lowed by N-acylated to dihydroceramides (DHCer) by a
family of Cer synthases (CerS) (Pewzner-Jung and
Futerman 2006). There are at least six mammalian CerS
that have varying degrees of speciﬁcity for fatty acyl-CoAs
(Riebeling et al. 2003; Lahiri and Futerman 2005; Mizutani
et al. 2005; Laviad et al. 2008) (Fig. 2a). The resultant
DHCer are converted to Cer via insertion of a 4,5-trans-
double bond into the sphingoid base backbone by dihydro-
ceramide desaturases (DES1 and DES2) (Michel et al.
1997). In mammalian cells, DES1 appears to have only
desaturase activity (Michel et al. 1997), whereas DES2 can
perform both desaturation and the 4 hydroxylation that
produces phytoceramides (Omae et al. 2004).
Headgroups
-H (Ceramide)    
-Phosphate (Sphingosine 1-Phosphate,
S1P;  Ceramide 1-Phosphate, Cer1P)
-Fatty acid (1-O-Acyl-Ceramide)
-Phosphocholine (Sphingomyelin)
-Phosphoethanolamine (Cer PE)
-Glucose (and higher glycan derivatives)
-Galactose (and higher glycan derivatives)
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Fig. 1 Basic structures of
sphingolipids (SP). a the
Cer backbone, with
N-palmitoylsphingosine as
an example; b headgroups
of mammalian SP, and
c major carbohydrates of
glycosphingolipids, and typical
symbols, with ganglioside GM1
as an example. The
abbreviations are as follows:
Glc, glucose; GlcNAc,
N-acetylglucosamine; Gal,
galactose; GalNAc,
N-acetylgalactosamine; Cer,
ceramide; LacCer, lactose
ceramide; GlcCer, glucose
ceramide; and NeuAc,
N-acetylneuraminic acid
308 Neuromol Med (2010) 12:306–319Note that So is not directly made in this pathway; rather,
Cer must be hydrolyzed to the free sphingoid base and fatty
acids by ceramidase (ceramidases are present in lysosomes
and other membranes) (Ferlinz et al. 2001; Linke et al.
2001; Tani et al. 2005). So can then undergo phosphory-
lation to form sphingosine-1-phosphate (S1P), which is
important in cell signaling (Maceyka et al. 2005, 2009) and
as an intermediate of SP turnover (sphinganine-1-phos-
phate, Sa1P, is also made, but its role in signaling is not
well deﬁned).
Cer is at the branchpoint for biosynthesis of complex SP
(Fig. 2b) by addition of various headgroups: phosphate
(from ATP) by ceramide kinase (CerK) (Van Overloop
et al. 2006); phosphocholine (for SM) transferred from
phosphatidylcholine SM synthases (SMS), with SMS1
localized to the Golgi and SMS2 localized to the plasma
membrane (Huitema et al. 2004); phosphoethanolamine for
ceramide phosphoethanolamine (CPE) by an SMS1-related
enzyme (SMSr) in the ER lumen that has been reported to
produce only trace amounts of CPE as a regulator of Cer
homeostasis (Vacaru et al. 2009).
GalCer and GlcCer, which are synthesized using uridine
diphosphate (UDP)-Glc:Cer glucosyltransferase (CGlcT)
and UDP-Gal:Cer galactosyltransferase (CGalT), respec-
tively, by adding the corresponding hexose from UDP-Gal
or UDP-Glc (Fig. 2b). The addition of a fatty acid to the
1-hydroxyl has also been described (Shayman and Abe
2000).
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Fig. 2 Sphingolipid
biosynthesis a A biosynthetic
pathway for the major
subspecies of dihydroceramides
(DHCer) and ceramides (Cer) of
mammalian SP. Shown from the
top is the de novo biosynthesis
of sphinganine (d18:0) by serine
palmitoyltransferase (SPT) and
3-ketosphinganine reductase
(gene name FVT1), followed by
either acylation of sphinganine
by Cer synthases (shown with
their fatty acyl-CoA
preferences) or phosphorylation
by sphingosine kinase (SphK).
b Headgroups added to the
subcategories of Cer shown in
panel A to make complex SP.
Shown on the left bottom panel
are Cer at the branch point for
formation of sphingomyelins
(SM), ceramide
phosphoethanolamines (CerPE),
Cer 1-phosphates (Cer1P),
glucosylceramides (GlcCer),
galactosylceramides (GalCer),
and 1-O-acylceramide. Also
shown on the right panel are the
pathways for the sulfatides and
root family glycans and
combinatorial nature of
glycosphingolipid biosynthesis
using symbols for the
headgroups (shown on the left
top panel)
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interesting. GalCer is synthesized in the lumen of the ER
versus GlcCer, which is thought to be made on cytosolic
facing membranes (Sprong et al. 2003). CGalT contains an
ER retrieval signal (a KKVK amino acid sequence) at the
C-terminus and the active site facing the lumen of the ER
at the N-terminus (Sprong et al. 1998) and has access to
UDP-Gal that is transported into the lumen of the ER by
UDP-Gal transporter 2 (UGT2), a splice variant of UGT1
(the transporter for UDP-Gal into the Golgi) that contains
an ER locating dilysine motif (KVKAS) (Kabuss et al.
2005). CGalT is highly expressed in oligodendrocytes and
Schwann cells, with a pattern that matches that of myeli-
nation (Bosio et al. 1996, 1998), and the disruption of
the mouse gene encoding CGalT leads to unstable myelin
and progressive paralysis in mouse models (Fewou et al.
2005). GalCer is a substrate for a sulfatotransferase in
the ER lumen that utilizes the activated sulfate donor
30-phosphoadenosine-50-phosphosulfate to form sulfatides
(30-sulfo-galactosylceramide, ST) (Honke et al. 1997). ST
are the major sulfoglycolipids of brain, kidney, the gas-
trointestinal tract and endometrium, and mammalian male
germ cells (Honke and Taniguchi 2003).
Most of the more complex GSP are synthesized by the
stepwise addition of carbohydrate molecules (e.g. galactose,
N-acetylgalactosamine, and sialic acid) to GlcCer mainly in
the Golgi apparatus by particular glycosyltransferases
(GTs) (Yu et al. 2004, 2009; Zeng and Yu 2008). Matured
GSP are transferred via vesicular transport to the cell sur-
face where they become components of the cell membrane.
The nature of the headgroup additions for the root family
GSP are illustrated in Fig. 2b. After the initial glycosyla-
tions, the pathway divides into ganglio-, lacto-, neolacto-,
globo-, and isogloboseries. The downstream pathways,
particularly for the gangliosides, have been described as
‘‘combinatorial’’ (Kolter et al. 2002) in analogy to combi-
natorial synthesis were common starting materials are uti-
lized to make many downstream products by adding them to
the reaction vessel in different combinations.
Gangliosides are an interesting prototype for the link
between GSP metabolism and biomedicine. It has long
been known that gangliosides show signiﬁcant differences
in expression levels and patterns in developing brains
(Davidsson et al. 1989; Svennerholm et al. 1989; Ngam-
ukote et al. 2007). For example, total gangliosides increase
in adult mouse brains when compared with embryonic
mouse brains and the expression pattern of gangliosides
shifts from relatively simple subspecies such as GM3 and
GD3 to more complex gangliosides, such as GM1, GD1a,
GD1b, and GT1b (Ngamukote et al. 2007). The dynamic
changes in gangliosides expression also observed during
the differentiation of embryonic and mesenchymal stem
cells into neural cells (Kwak et al. 2006). Gangliosides
bind to myelin-associated glycoprotein (MAG) and play
essential roles in maintaining axon–myelin stability and
functions (Quarles 2007). Mice lacking the ganglioside
biosynthetic gene Galgt1 fail to express complex ganglio-
sides and exhibited central nervous system and peripheral
nervous system axon degeneration and dysmyelination
quantitatively and qualitatively similar to that of Mag null
mice (Pan et al. 2005) and have disruption in the paranodal
junctions and ion channel clusters at the nodes of Ranvier
(Susuki et al. 2007).
Sphingolipid Turnover
With the exception of specialized cases of turnover for cell
signaling, SP are generally thought to turn over via a
process that involves internalization with endocytic vesi-
cles, sorting in early endosomes, and recycling of some
portions of the sphingolipid back to the plasma membrane
(often with remodeling of the sphingolipid) (Tettamanti
et al. 2003) or transport or the remainder to lysosomes
where they are degraded by speciﬁc acid hydrolases
(Kolter and Sandhoff 2006). In lysosome, GSP are catab-
olized by the stepwise hydrolysis of the terminal mono-
saccharides through the concerted action of a series of
speciﬁc exoglycosidases and sphingolipid activator pro-
teins (which include SAP-A, SAP-B, SAP-C or SAP-D,
and GM2-activator protein) (Kolter and Sandhoff 2006;
Schulze et al. 2009), as summarized in Fig. 3. These
pathways are also connected to numerous inherited dis-
eases arising from mutations in the genes encoding these
enzymes and/or activator proteins, as is also summarized in
Fig. 3. These so-called sphingolipid storage diseases often
result in an accumulation of the corresponding lipid sub-
strate in brain (and other organs) (van Echten-Deckert and
Herget 2006).
Sphingolipid Analysis
SP can be analyzed by a variety of traditional methods, such
as thin-layer chromatography (TLC), high-performance
liquid chromatography (HPLC), immunochemical meth-
odologies, and mass spectrometry (MS), which is the most
commonly used method nowadays because it can identify
and quantify large numbers of sphingolipid molecules with
a high degree of structural accuracy (Sullards 2000; Haynes
et al. 2009; Shaner et al. 2009). Various ionization methods
have been applied, including electrospray ionization, ESI;
atmospheric pressure chemical ionization, APCI, and
matrix-assisted laser-desorption ionization (MALDI),
combined with triple quadrupole or tandem quadrupole-
linear ion trap mass analyzers for MS/MS and MS
n
310 Neuromol Med (2010) 12:306–319(Sullards et al. 2007; Shaner et al. 2009), respectively, or for
higher mass accuracy, time-of-ﬂight (TOF) (Kirsch et al.
2008), or Fourier transform (FT) instruments (McFarland
et al. 2005; Vukelic et al. 2007; Pol et al. 2009).
SP are particularly amenable to ESI and MALDI mass
spectrometric analyses because they are relatively easily
ionized (thus can be detected with high sensitivity that
allows analysis of relatively small numbers of cells) and
form fragment ions that are characteristic for the headgroup
and backbone subclasses. For examples, both long-chain
bases and complex SP ionize well via ESI in the positive
ion mode to produce protonated molecular ions (M ? H)
?.
Alternatively, sphingoid base-1-phosphates, ST, SM, and
gangliosides form strong ions of the type (M–H)
-,
(M–15)
-, or (M–nH)
n- (i.e., the original molecular ion
minus a proton, a methyl group or multiple hydrogens,
respectively) via negative ion ESI, depending on the
composition of the solvent (Merrill et al. 2005). The
fragmentation proﬁles for both sphingoid bases and many
complex SP can be obtained by MS/MS and multistage
tandem MS (MS
n) analysis, which provide structural
information about the headgroups and types of sphingoid
bases and fatty acids in the lipid backbones (Fig. 4).
MALDI usually uses matrix molecules to assist the
efﬁcient production of singly charged ions, which in
conjunctionwith thehighm/zrange ofTOFinstruments,has
aided in the observation of higher molecular weight GSPs.
Therefore, studies of more complex GSPs often utilize this
technique (Suzuki et al. 2006; Landoni et al. 2008; Chan
et al. 2009). One disadvantage of MALDI is that matrices
produce abundant background chemical noise at lower m/z
values, which precludes analysis of free sphingoid bases.
However, new advances in matrix choices and high pressure
sources may provide an opportunity to study these lower
molecularweightSPbyMALDI(Nakamuraetal.2006;Cha
and Yeung 2007; Stuebiger and Belgacem 2007; Astigar-
raga et al. 2008; Goto-Inoue et al. 2008; Zarei et al. 2008).
The combination of MS with liquid chromatography
(Sommer et al. 2006; Sullards et al. 2007; Shaner et al.
2009) has been successful in meeting difﬁcult analytical
challenges by reducing ionization suppression effects from
other species and allowing the separation of isomeric and
isobaric species, which cannot be achieved by mass spec-
trometry alone. Two types of HPLC are mainly chosen for
SP separation in HPLC–MS/MS: reversed phase LC (Lee
et al. 2003; Kaga et al. 2005; Merrill et al. 2005; Shaner
et al. 2009) for separations based on the length and satu-
ration of acyl chains (for example, to separate So and Sa)
and normal phase LC (Pettus et al. 2004; Merrill et al.
2005; Pacetti et al. 2005; Farwanah et al. 2007; Farwanah
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Fig. 3 Catabolism of complex SP and diseases associated with
deﬁciencies in these enzymes and/or activator proteins (Kolter and
Sandhoff 2006). The color symbols and scheme for these compounds
are the same as shown in Fig. 1 and 2. The SP turnover-related
diseases are indicated by number with: (1) GM1-gangliosidosis; (2)
Tay-Sachs disease/Sandhoff AB variant; (3) Sandhoff disease; (4)
Fabry disease; (5) Sialidosis; (6) Gaucher disease; (7) metachromatic
leukodystrophy; (8) globoid cell leukodystrophy/Krabbe disease; (9)
Niemann Pick disease; (10) Farber disease. The abbreviations are as
follows: Choline-P phosphatidylcholines; Et-P phosphatidylethanol-
amine; Glc glucose; GlcNAc N-acetylglucosamine; Gal galactose;
GalNAc N-acetylgalactosamine; and NeuAc, N-acetylneuraminic acid
Neuromol Med (2010) 12:306–319 311et al. 2009) to separate compounds primarily by their
headgroup constituents (for example, distinguish Cer,
GlcCer, LacCer, globotriaosylceramide, globotetraosyl-
ceramide, SM as well as cholesterol, etc.). HPLC–MS/MS
has been used to quantify and determine the structures of
free sphingoid bases, free sphingoid base phosphate, Cer,
monohexosylceramide (both GalCer and GluCer), LacCer,
SM (Sullards and Merrill 2001; Pettus et al. 2003; Bie-
lawski et al. 2006; Yoo et al. 2006), and more complex
GSP (Merrill et al. 2005; Ikeda et al. 2008).
Currently, LC–ESI MS/MS is the most popular analyt-
ical tool for sphingolipid analysis, because it provides (1) a
high level of speciﬁcity with regard to differentiation of
complex molecular species via retention time, precursor
ion m/z value, and structure-speciﬁc product ion m/z value,
(2) high sensitivities that are orders of magnitude better
than those of classical techniques, which enables detection
of SP in minute quantities (*fmol or less) in small bio-
logical samples (*10
6 cells), (3) a wide dynamic range
(typically several orders of magnitude) for quantitation of
SP, and (4) the potential of accurate and precise quantita-
tion in complicated biological samples using appropriate
internal standards (C. Haynes, 2009). Different classes of
gangliosides (i.e. GM1, GM2, GM3, GD3, GD1a, GD1b,
GT1b, GQ1b) in the rat brain can be fast and efﬁciently
quantiﬁed with high sensitivity using LC–ESI MS/MS
(Fong et al. 2009). Regioisomeric gangliosides, such as
GM1a and GM1b, GD1a, GD1b, and GD1c, and GT1a,
GT1b, and GT1c, with diagnostic sugar chains have also
been effectively separated and distinguished by theoreti-
cally expanded multiple reaction monitoring of LC–ESI
MS/MS (Ikeda et al. 2008).
New Technologies for Sphingolipid Analysis
Although the methods described earlier are powerful
approaches to study many SP, there still are many chal-
lenges for sphingolipidomic analysis, which refer to the
structure-speciﬁc and quantitative measurements of all the
individual molecular species of SP so that the quantity of
each one in a given biological context (i.e. manipulated
biosynthesis or turnover) may be determined. The sphin-
golipidome could contain tens of thousands of SP because
there are over 400 headgroup subcategories in mammals
alone (www.sphingomap.org) (Merrill et al. 2007, 2009),
and many have at least several to a few dozen backbone
variants on sphingoid bases and fatty acids. The current
analytical challenges include the needs for proﬁling all the
SP in a speciﬁc biological system (such as central nervous
system), knowing the location of these molecules, and
obtaining information about their metabolic ﬂux.
Two-dimensional (2-D) ESI MS/MS techniques have
been introduced for the identiﬁcation, structure determina-
tion, and quantitation of sphingolipidomic analysis (Han
and Gross 2003; Han and Jiang 2009; Stahlman et al. 2009).
This technique (also called ‘‘shotgun’’ lipidomics) utilizes
MS and MS/MS in both positive and negative ESI condi-
tions to analyze an infusion sample (usually dissolved in
chloroform, which provides good lipid solubility and high
sensitivity). The formation of charged molecular adducts in
the positive mode and anionic species in the negative mode
is promoted by the presence of aqueous LiOH and LiCl,
respectively. This technique is a relatively fast and simple
method to proﬁle many SP and glycerol lipids in crude lipid
extracts. It has been used to examine the lipid composition
R = H, H2PO3, 
Carbohydrate, +
+
-H 2O
Sphingosines m/z 264
Sphinganines m/z 266
4-Hydroxysphinganines
(double dehydration) m/z 282
(triple dehydration) m/z 264
OH
NH3
OR
(Dihydro)ceramides
+
NH3
OR
+
+
NH3
H+ HO
NH
OR
O
m/z 184
OH
NH
OPhosphocholine
O
Sphingoid bases & derivatives
Sphingomyelins
m/z 264
(266, etc.)
Glycosphingolipids
OH
O HO
OH
O
O
OH
OH
O R'
HN R"
O
OH
Z0
Y0
Z1
Y1
B1
C1
B2
C2
0
4
5
2
1
2
3
1 3
0 4
1,5X2
5
2,5A2
HO
HO
m/z 264
(266, etc.)
Fig. 4 Major fragmentation
sites of SP and ions that are
often used for analysis by
electrospray ionization tandem
mass spectrometry in the
positive ion mode (Merrill et al.
2005)
312 Neuromol Med (2010) 12:306–319of the brain mitochondria, which can help to determine
whether intrinsic lipid abnormalities underlie mitochondrial
dysfunction associated with neurological and neurodegen-
erative diseases (Kiebish et al.2009). A varietyof very-low-
abundance sphingolipid classes (e.g., So, psychosine, and
lysosphingomyelin) and other SP species (e.g., SM) in brain
were also identiﬁed and quantitated using this approach
(Jiang et al. 2007). However, it should be noted that the
possibility of ionization suppression and the inability to
distinguish isomeric and isobaric species are main limita-
tions of this non-LC method.
The use of nanospray combined with high resolution MS
and MS/MS analysis via tandem mass spectrometers is an
innovative extension of the 2-D lipid proﬁling technique
(Ekroos et al. 2002). This method usually uses a chip
containing a high-density array of nanospray nozzles to
infuse very small volumes of sample into the mass spec-
trometer. It allows numerous product ion analyses to be
performed incrementally across a desired mass range. The
resulting product ion data is then queried for structure-
speciﬁc fragment ions or neutral losses corresponding to
unique lipid fragmentations to reveal the individual head-
group, fatty acid, and sphingoid base combinations of
various intact lipid species in the sample. The high reso-
lution and mass accuracy of the mass analyzer also allows a
narrower precursor ion window, resulting in a better
selection of lipid of interest (Haynes et al. 2009). Chip-
based nanoelectrospray ionization tandem mass spectrom-
etry has demonstrated the capability of observing structural
and composition differences of gangliosides (such as tri-
sialoganglioside subspecies with different fatty acid chain
lengths) between normal and benign tumorous frontal
cortex tissues (Schiopu et al. 2009). It has also been used to
identify complex and distinctive gangliosides (such as GD,
GT, GM, LM, GQ subspecies) in human gliosarcoma
(Vukelic et al. 2007). Since all infusion-based techniques
have limitations concerning unambiguous identiﬁcation
and, more importantly, quantitation of SP, newer chip-
based nanospray systems allow the HPLC column to be
directly coupled to the chip and enable simultaneous
fraction collection of excess eluent. Using this technology,
complex mixtures can be separated, and the analytes are
selectively eluted under conditions with minimized ioni-
zation suppression effects. Isotopic, isomeric, and isobaric
effects can also be differentiated easily. The resulting
LC–MS or MS/MS data may then be used for quantitation
when the kinetic and dynamic range problems are solved
and the appropriate internal standards are included.
Detailed structural information can also be obtained by
analyzing a particular fraction containing an analyte of
interest in greater detail (i.e. MS
n) (Haynes et al. 2009).
The recent development of ion mobility mass spec-
trometry has demonstrated additional possibilities to
achieve separation of lipids (Jackson et al. 2005). In this
technique, different ions with the same m/z value (isomers)
are separated based on differences in their mobility through
a buffer gas and applied electric ﬁeld (Verbeck et al. 2002).
The mobilities of different ions are directly affected by their
three-dimensional shapes, e.g. ions with a greater cross-
section migrate slower (Verbeck et al. 2002; Fenn et al.
2009; Trimpin et al. 2009). Thus, it is possible to distinguish
the different conformations of ions having the same m/z
(Liu and Clemmer 1997; Clowers et al. 2005). This new
technology offers the potential to differentiate isomeric
sphingolipid species for subsequent identiﬁcation and
quantitation that currently can only be achieved via LC.
Imaging mass spectrometry is another emerging tech-
nology that not only identiﬁes various classes of molecules
but also determines their spatial distributions in biological
samples. Imaging mass spectrometry is beginning to allow
analysis of SP in situ using samples such as thin slices of
tissue, cultured cells and model membranes. One of the
methods is MALDI imaging mass spectrometry in which
samples (such as brain slices) are placed on a MALDI
plate, imbedded as uniformly and non-disruptively as
possible with matrix material serving to enhance the
desorption and ionization of analytes in the sample. Then,
the sample is scanned by the laser beam incrementally to
generate discrete mass spectra (Chaurand et al. 2006; Roy
et al. 2006; Jackson et al. 2007a; b) The intensity of a
speciﬁc ion of interest can then be assigned different colors
and plotted in x,y-space to yield a molecular image of the
biological sample. This may then be cross-referenced with
a histologic image using standard methods generated from
the same sample or a similar neighboring sample. In
another imaging technique, secondary ion mass spectrom-
etry (SIMS), a beam of primary ions is tightly focused to
impinge on the surface of the biological sample to ionize
compounds of interest (Sjovall et al. 2004; Roy et al. 2006;
Benabdellah et al. 2010). SIMS provides better spatial
resolution for lower mass species than MALDI, whereas
MALDI is more amenable to higher mass analytes. An
additional ambient imaging technique, desorption electro-
spray ionization (DESI), uses charged droplets of solvent
generated from an electrospray to generate the secondary
ions to provide molecular image of biological samples with
much easier experimental procedure but even lower spatial
resolution than MALDI imaging (Wiseman et al. 2006;
Manicke et al. 2008). Additional techniques are emerging
where MALDI is combined with another method of ion
separation, such as ion mobility-MS which gives two-
dimensional separations based on analyte apparent surface
area or collision cross section as well as mass-to-charge
[McLean et al. (2007)].
Applied to brain tissues, MALDI imaging has observed
primary SP such as SM, monohexosylceramides, ST, and
Neuromol Med (2010) 12:306–319 313gangliosides (Jackson et al. 2007b; Jackson and Woods
2009; Murphy et al. 2009) as well as the speciﬁc locali-
zation of their subcategories in different brain regions. It
has been reported that the cerebellar cortex contains small
amounts of SM and larger amounts of gangliosides GM1,
GD1, and GT1, whereas the cerebellar peduncle contains
sulfatides and primarily GM1 with smaller quantities of
GD1 (Woods and Jackson 2006). In another study of Tay-
Sachs and Sandhoff disease, MALDI imaging mass
spectrometry, GM2 and asialo-GM2 (GA2) subspecies
were found highly elevated in diseased brain and specif-
ically localized in the granular cell region of the cere-
bellum, whereas ST was localized mainly in myelinated
ﬁber (white matter) region of the cerebellum as well as in
the brain stem with a relatively uniform distribution and
had similar relative signal intensity for both normal and
diseased brain. Many subcategories of other lipids (such
as phosphatidylcholines, phosphatidylinositol, plasmeny-
lethanolamine, phosphatidylserine) were also localized to
speciﬁc regions of the brain (Chen et al. 2008a). Long-
chain base (LCB) gangliosides with C18- or C20-sphin-
gosine have also been found to localize differentially in
the mouse brain by MALDI imaging mass spectrometry
(Chen et al. 2008b; Sugiura et al. 2008). The C18-species
was widely localized throughout the frontal brain,
whereas the C20-species selectively distributed along the
entorhinal-hippocampus projections, especially in the
molecular layer of the dentate gyrus (Sugiura et al. 2008).
SIMS TOF has also been used to analyze brain slices to
reveal the different distributions of GalCer subspecies in
white matter. The C18 GalCer subspecies were mainly
found in cholesterol-rich areas, whereas C24 GalCer
subspecies were primarily distributed in Na
?- and K
?-
enriched regions (Borner et al. 2006). While imaging
mass spectrometry has limitations with respect to pro-
viding quantitative information (Murphy et al. 2009), the
ability to reveal the cellular—and eventually subcellu-
lar—location of the molecules of interest will be a major
complement to sphingolipid analysis and sphingolipido-
mic biology.
Conclusion
SP are comprised of thousands of species that encompass
bioactive backbones and complex phospho- and glycolipids
that nature has chosen to make for equally sophisticated
biological functions. The challenge for researchers is to
develop methods that are powerful enough to deal with this
complexity. Although there is still a long way to go, the
application of relatively recently developed analytical
methods for SP is already helping clarify the roles of these
compounds in neural cell behavior and disease.
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